Michael Savona

Michael Savona, MD, is currently Director of Hematologic Malignancies Research and Early Therapy Program, and Professor of Internal Medicine and Cancer Biology at Vanderbilt University Medical Center in Nashville, TN, USA.

He is specializing in myeloid malignancies, and has led development and approval of several novel therapies targeting the proteosome, BCL2 family proteins, PI3 kinase delta, the JAK/STAT pathway, and various epigenetic agents.